Web-based empowerment program for heart attack recovery
Supporto Alla Prevenzione Cardiovascolare Secondaria Post-IAM Attraverso un Programma di Empowerment Web-based (PREVEN-IAM)
NA · Centro Cardiologico Monzino · NCT05782023
This study tests a web-based program designed to help heart attack survivors adopt healthier habits and prevent future heart problems.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Centro Cardiologico Monzino (other) |
| Locations | 1 site (Milan) |
| Trial ID | NCT05782023 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a web-based empowerment program aimed at secondary cardiovascular prevention in patients who have experienced an acute myocardial infarction (AMI). The program begins with an in-hospital assessment of risk factors, followed by ongoing digital interactions that promote healthy behaviors such as smoking cessation, improved diet, and regular exercise. The intervention is personalized, involves shared decision-making, and includes a multidisciplinary team of healthcare professionals. Participants will also receive periodic follow-ups and assessments to monitor their progress and satisfaction with the program.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have experienced a STEMI or NSTEMI and have access to digital communication devices and the internet.
Not a fit: Patients with active malignancies, severe cognitive impairments, or those who do not foresee continuing cardiology follow-up at the site may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve recovery and long-term health outcomes for heart attack patients by empowering them to manage their cardiovascular health.
How similar studies have performed: Other studies have shown promising results with similar digital empowerment approaches in managing cardiovascular health, indicating potential for success in this novel intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * STEMI or NSTEMI * availability of digital communication devices (smart-phone, tablet or personal computer) and internet access Exclusion Criteria: * active malignancies (except for skin tumors other than melanoma) * life expectancy \<5 years * absolute clinical indication to undergo hospital rehabilitation cycles * cognitive status undermining digital communication devices use, even after proper training * low understanding of Italian language, either oral or written, by clinician's judgement * patient not foreseeing to undergo cardiology follow-up at the site
Where this trial is running
Milan
- Centro Cardiologico Monzino — Milan, Italy (RECRUITING)
Study contacts
- Principal investigator: José P Werba, MD — Centro Cardiologico Monzino
- Study coordinator: José P Werba, MD
- Email: pablo-werba@cardiologicomonzino.it
- Phone: +39 0258002619
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Myocardial Infarction, acute myocardial infarction, secondary prevention, atherosclerosis, health empowerment